COVID-19 treatment Archive — Page 4 of 11

Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
October 5, 2021

AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC

Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19.

By Bill Snyder
Conceptual 3D illustration of red, spiked SARS-CoV-2 particles surrounded by Y-shaped ACE2 receptors on a glowing orange background.
October 1, 2021

VUMC research contributed to first COVID-19 pill now under review

Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.

By Bill Snyder
Michelle Izmaylov, a medical student, poses against a light background wearing a white medical coat over a navy-and-white striped shirt.
September 23, 2021

From fantasy fiction to patient narratives, the power of storytelling drives Michelle Izmaylov

“If you just simply sit with someone and listen, you will learn incredible things”

By Emily Stembridge
Portrait of Jeff Balser, MD, PhD, wearing glasses, a dark suit, white shirt, and patterned tie.
September 22, 2021

Rounds: Hard conversations

By Doug Campbell
Three-dimensional illustration of a coronavirus particle with a textured gray spherical surface, red spike proteins, and smaller yellow surface structures; blurred particles appear in the background.
September 2, 2021

Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.

By Nancy Humphrey
Jim Jackson poses in a hospital clinic hallway, wearing a dark blazer over a blue-and-white checkered shirt.
September 2, 2021

A leading authority in ICU-related depression and PTSD, Jim Jackson’s skills have proven especially critical to helping patients during the pandemic

“The last year has been so traumatizing and hard, but to use the skills and knowledge that we have been developing to good effect in the service of others during this difficult season has been meaningful.”

By Bill Snyder